Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AEHR TEST SYSTEMS Director's Dealing 2021

Oct 13, 2021

32300_dirs_2021-10-13_c9888af4-0057-46bd-8c36-3cd28dd1c74e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AEHR TEST SYSTEMS (AEHR)
CIK: 0001040470
Period of Report: 2021-10-11

Reporting Person: Brannan Michael A. (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-10-11 Common Stock M 14000 $1.2200 Acquired 28826 Direct
2021-10-11 Common Stock S 17000 $18.8000 Disposed 11826 Direct
2021-10-12 Common Stock M 14125 $1.2200 Acquired 25951 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-10-11 Incentive Stock Option (right to buy) $1.2200 M 14000 Disposed 2027-03-16 Common Stock (14000) Direct
2021-10-12 Incentive Stock Option (right to buy) $1.2200 M 14125 Disposed 2027-03-16 Common Stock (14125) Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.35 to $19.67, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.

F2: The amount reported includes shares subject to unvested restricted stock units.

F3: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter.